Prevention of Pneumocystis carinii pneumonia: Who are we missing?

被引:15
|
作者
Schwarcz, SK
Katz, MH
Hirozawa, A
Gurley, J
Lemp, GF
机构
[1] S. Francisco Dept. Pub. Hlth., E., San Francisco, CA
[2] S. Francisco Dept. Pub. Hlth., E., San Francisco, CA 94102
关键词
Pneumocystis carinii pneumonia; chemoprophylaxis; HIV; AIDS; health-care utilization; cost;
D O I
10.1097/00002030-199710000-00010
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To obtain population-based information on the characteristics of persons who were not receiving chemoprophylaxis against Pneumocystis carinii pneumonia (PCP) by examining the use of primary and secondary PCP prophylaxis among San Francisco residents whose AIDS-defining opportunistic illness was PCP in 1993. Design: Retrospective medical record review. Setting: Medical charts were obtained From San Francisco hospitals and outpatient facilities at which AIDS patients received their initial AIDS diagnosis. Participants: San Francisco residents whose AIDS-defining opportunistic illness was PCP in 1993. Main outcome measures: Use of primary and secondary PCP prophylaxis. Results: Of the 326 eligible patients, 35% received primary PCP prophylaxis. Nonwhites were significantly less likely to have received primary PCP prophylaxis than white patients [22 versus 40%, respectively; odds ratio (OR), 0.49195% confidence intervals (CI), 0.28-0.87]. Uninsured individuals were also less likely to have received primary PCP prophylaxis than those with insurance (18 versus 41%, OR, 0.35; 95% Cl, 0.17-0.73). The sociodemographic characteristics of patients who did and did not receive secondary PCP prophylaxis did not differ significantly. The most frequently cited reasons for not receiving primary PCP prophylaxis were that patients were unaware of their infection with HIV or were not receiving regular medical care. Conclusions: Barriers to receipt of PCP prophylaxis exist and are resulting in cases of preventable disease and unnecessary medical costs. Interventions to increase counseling, testing, and referral to medical care for pet-sons at high risk for HIV infection are needed.
引用
收藏
页码:1263 / 1268
页数:6
相关论文
共 50 条
  • [1] PREVENTION OF PNEUMOCYSTIS-CARINII PNEUMONIA
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 1988, 30 (776): : 94 - 95
  • [2] THE PREVENTION OF PNEUMOCYSTIS-CARINII PNEUMONIA
    HUGHES, WT
    HOSPITAL PRACTICE, 1990, 25 (4A): : 33 - 43
  • [3] PREVENTION OF PNEUMOCYSTIS-CARINII PNEUMONIA
    MASUR, H
    REVIEWS OF INFECTIOUS DISEASES, VOL 11, SUPPL 7: CONTROVERSIES IN THE MANAGEMENT OF INFECTIOUS COMPLICATIONS OF NEOPLASTIC DISEASES, 1989, : S1664 - S1668
  • [4] Treatment and prevention of Pneumocystis carinii Pneumonia
    Goebel, FD
    Bogner, JR
    INTERNIST, 1995, 36 (12): : 1150 - 1155
  • [5] PREVENTION AND TREATMENT OF PNEUMOCYSTIS-CARINII PNEUMONIA
    HUGHES, WT
    ANNUAL REVIEW OF MEDICINE, 1991, 42 : 287 - 295
  • [6] Pneumocystis Pneumonia (PCP) - Pneumocystis carinii pneumonia
    Vogel, M
    Hierl, T
    Horger, M
    ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN, 2005, 177 (07): : 919 - 921
  • [8] PREVENTION OF PNEUMOCYSTIS-CARINII PNEUMONIA IN CHILDREN WITH CANCER
    PUI, CH
    HUGHES, WT
    EVANS, WE
    CRIST, WM
    JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (07) : 1522 - 1522
  • [9] PREVENTION OF PNEUMOCYSTIS-CARINII PNEUMONIA BY INHALED PENTAMIDINE
    GOLDEN, JA
    HOLLANDER, H
    CHERNOFF, D
    FEIGAL, D
    CONTE, JE
    LANCET, 1989, 1 (8639): : 654 - 657
  • [10] PREVENTION OF PNEUMOCYSTIS-CARINII PNEUMONIA WITH PENTAMIDINE INHALATION
    JABLONOWSKI, H
    ELSING, C
    ERCKENBRECHT, J
    HENGELS, KH
    STROHMEYER, G
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1992, 117 (31-32) : 1181 - 1184